Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.200 | 11 | 108309110 | intron variant | A/G | snv | 2.4E-05 | 4.2E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases; Nervous System Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 10 | 1996 | 2015 | ||||||
|
0.925 | 0.200 | 11 | 108309110 | intron variant | A/G | snv | 2.4E-05 | 4.2E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 7 | 1996 | 2017 | ||||||
|
0.827 | 0.200 | 11 | 108412434 | intron variant | C/A | snv | 0.49 |
|
Endocrine System Diseases | 0.020 | 0.500 | 2 | 2012 | 2012 | |||||||
|
0.827 | 0.200 | 11 | 108412434 | intron variant | C/A | snv | 0.49 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2012 | 2014 | |||||||
|
0.827 | 0.200 | 11 | 108412434 | intron variant | C/A | snv | 0.49 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.020 | 0.500 | 2 | 2012 | 2012 | |||||||
|
0.827 | 0.200 | 11 | 108412434 | intron variant | C/A | snv | 0.49 |
|
0.700 | 1.000 | 2 | 2011 | 2011 | ||||||||
|
1.000 | 11 | 108444879 | intron variant | C/T | snv | 1.6E-02 |
|
0.700 | 1.000 | 2 | 2018 | 2019 | |||||||||
|
1.000 | 11 | 108444879 | intron variant | C/T | snv | 1.6E-02 |
|
Neoplasms | 0.700 | 1.000 | 2 | 2018 | 2019 | ||||||||
|
0.882 | 0.080 | 11 | 108348120 | intron variant | A/G | snv | 0.16 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.080 | 11 | 108348120 | intron variant | A/G | snv | 0.16 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.080 | 11 | 108348120 | intron variant | A/G | snv | 0.16 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.827 | 0.200 | 11 | 108412434 | intron variant | C/A | snv | 0.49 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.827 | 0.200 | 11 | 108412434 | intron variant | C/A | snv | 0.49 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.827 | 0.200 | 11 | 108412434 | intron variant | C/A | snv | 0.49 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.080 | 11 | 108364109 | intron variant | A/C;T | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||||
|
1.000 | 0.080 | 11 | 108344670 | intron variant | T/G | snv | 6.7E-02 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.080 | 11 | 108344670 | intron variant | T/G | snv | 6.7E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
11 | 108378047 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
11 | 108378047 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
11 | 108378047 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
11 | 108378047 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
11 | 108378047 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
11 | 108352074 | intron variant | C/A | snv | 0.52 |
|
0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||||
|
0.882 | 0.160 | 11 | 108334154 | intron variant | C/T | snv | 0.27 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.882 | 0.160 | 11 | 108334154 | intron variant | C/T | snv | 0.27 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 |